| Project/Area Number |
21791152
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Psychiatric science
|
|---|
| Research Institution | St.Marianna University School of Medicine |
|---|
Principal Investigator |
TAKAHASHI Kiyofumi St.Marianna University School of Medicine, 医学部, 研究技術員 (70398965)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
MIYOSHI Hiroshi 聖マリアンナ医科大学, 医学部, 講師 (80322519)
|
|---|
| Project Period (FY) |
2009 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2010: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2009: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 脳・神経 / 向精神薬 / エンドサイトーシス / Dynamin |
|---|
| Research Abstract |
Sertraline, an antidepressant belonging to selective serotonin reuptake inhibitors (SSRI), inhibits GTPase activity of dynamin which plays an important role in membrane fission on endocytosis. It was revealed that sertraline is a mixed-type inhibitor of the GTPase activity with respect to both guanosine 5'-triphosphate (GTP) and 3-sn-phosphatidyl-L-serine (PS)-liposome, and does not inhibit dynamin self-assembly for oligomerization.
|
